menu
    • menu

    Company profile for Dianthus Therapeutics

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    With Virupaksha, you get a quality product with on-time delivery.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    ChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & new modalities with ICH-grade quality.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Dianthus Therapeutics is advancing next generation complement therapeutics to deliver transformative medicines for patients with rare diseases. Our mission is to develop best-in-class, potent and selective antibodies of validated and emerging complement targets to transform the lives of people living with autoimmune diseases.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Dianthus TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    Waltham, Massachusetts
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://dianthustx.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dianthus-therapeutics-inc/about/
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/dianthustx

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    DDL Conference

    Not Confirmed

    envelop Contact Supplier

    DDL Conference

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Dianthus Therapeutics at 8th Evercore Healthcare Conference
    Dianthus Therapeutics at 8th Evercore Healthcare Conference

    24 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/24/3193377/0/en/Dianthus-Therapeutics-To-Participate-in-the-8th-Annual-Evercore-Healthcare-Conference.html

    GLOBENEWSWIRE
    24 Nov 2025
    Share Share
    Dianthus Therapeutics Showcases Business Successes, Reveals Q3
    Dianthus Therapeutics Showcases Business Successes, Reveals Q3

    05 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/05/3181899/0/en/Dianthus-Therapeutics-Highlights-Recent-Business-Achievements-and-Reports-Q3-Financial-Results.html

    GLOBENEWSWIRE
    05 Nov 2025
    Share Share
    Dianthus Therapeutics Joins Four Investor Conferences In November
    Dianthus Therapeutics Joins Four Investor Conferences In November

    04 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/04/3180280/0/en/Dianthus-Therapeutics-to-Participate-in-Four-Investor-Conferences-During-November.html

    GLOBENEWSWIRE
    04 Nov 2025
    Share Share
    Dianthus Therapeutics Showcases Latest Claseprubart Data at 2025
    Dianthus Therapeutics Showcases Latest Claseprubart Data at 2025

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176817/0/en/Dianthus-Therapeutics-Highlights-New-Claseprubart-Data-Presented-During-2025-AANEM-Annual-Meeting.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    Dianthus Therapeutics Licenses DNTH212, To Leads Biolabs
    Dianthus Therapeutics Licenses DNTH212, To Leads Biolabs

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3167762/0/en/Dianthus-Therapeutics-Announces-Exclusive-License-Agreement-with-Leads-Biolabs-for-DNTH212-a-First-and-Potentially-Best-In-Class-Phase-1-Ready-Bifunctional-BDCA2-BAFF-APRIL-Inhibit.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    Dianthus Therapeutics To Present Claseprubart Data At 2025 AANEM
    Dianthus Therapeutics To Present Claseprubart Data At 2025 AANEM

    02 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/02/3160307/0/en/Dianthus-Therapeutics-Highlights-Claseprubart-Data-Presentations-Planned-for-2025-AANEM-Annual-Meeting.html

    GLOBENEWSWIRE
    02 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search